Hemo Organic Limited announced significant corporate developments following its board meeting held on February 26, 2026. The company's board approved the allotment of convertible warrants and relocation of its registered office within Ahmedabad.

Convertible Warrants Allotment

The board approved the allotment of 34,00,000 convertible warrants to non-promoter entities at Rs. 12.50 per warrant, including a premium of Rs. 2.50 each. The warrants carry a face value of Rs. 10.00 each and are convertible within 18 months from the allotment date.

The allotment was made on a preferential basis in accordance with Chapter V of SEBI (ICDR) Regulations, 2018. Each warrant is convertible into one fully paid-up equity share upon payment of the remaining 75.00% of the issue price.

Allottee Details

The warrants were allocated equally between two private limited companies:

Impact on Share Capital

Upon full conversion of the warrants, the company's capital structure will undergo significant expansion:

The new equity shares will rank pari-passu with existing equity shares, ensuring equal rights and privileges for all shareholders.

Registered Office Relocation

The board also approved shifting the company's registered office within Ahmedabad. The new address is Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350. The relocation became effective from February 26, 2026.

The board meeting commenced at 02:15 P.M. and concluded at 02:45 P.M. on February 26, 2026, with Managing Director Vishwambar Kameshwar Singh overseeing the proceedings.

Hemo Organic Limited has issued an official notice for its Extra-Ordinary General Meeting (EGM) scheduled for January 7, 2026, at 4:00 PM through video conferencing. The meeting will seek shareholder approval for increasing authorized share capital and issuing convertible warrants worth ₹12.47 crores to non-promoter investors.

EGM Details and Voting Process

The company has set December 31, 2025, as the cut-off date for determining eligible shareholders for voting rights. Remote e-voting will be available from January 4, 2026, at 9:00 AM to January 6, 2026, at 5:00 PM through NSDL's e-voting platform.

Authorized Capital Increase Resolution

Shareholders will vote on increasing the company's authorized share capital through an ordinary resolution. The proposal aims to accommodate future business requirements and growth prospects.

The increase will enable the company to issue new shares ranking pari passu with existing equity shares, with corresponding alterations to the Memorandum of Association.

Convertible Warrant Issue Details

The second agenda involves a special resolution for issuing 99.75 lakh convertible warrants to non-promoter category investors. The warrants carry an 18-month conversion period from the allotment date.

Proposed Allottee Distribution

The warrants will be allocated among three non-promoter investors, with Managing Director Vishwambar Kameshwar Singh being the largest individual allottee.

Pricing and Fund Utilization

The issue price of ₹12.50 per warrant has been determined based on SEBI ICDR regulations, considering the higher of 90-day and 10-day volume-weighted average prices. The floor price computed under SEBI regulations stands at ₹12.45 per share.

A valuation report from Procurve Valux Private Limited, a registered valuer entity, supports the pricing determination. The report dated December 11, 2025, is available for inspection at the company's registered office and website.

Regulatory Compliance and Lock-in

Warrant holders must pay 25% of the issue price upfront, with the remaining 75% payable during conversion to equity shares. The resulting equity shares will be subject to lock-in provisions as per SEBI ICDR regulations, with additional lock-in periods as mutually agreed between the company and allottees.

The company has appointed Jay Pandya & Associates as the scrutinizer for the e-voting process, ensuring fair and transparent conduct of the meeting. The allotment will be completed within 15 days of the special resolution passage, subject to regulatory approvals.